Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|November 9, 2011
Fatigue in out-patients with inflammatory bowel disease is common and multifactorialP Bager, R Befrits, O Wikman, et al.
Scandinavian Journal of Gastroenterology|September 21, 2018
Anemia following Roux-en-Y gastric bypass for morbid obesity; a 5-year follow-up studyK V Engebretsen, I K Blom-Høgestøl, S Hewitt, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of GastroenterologistsB Moum, M H Vatn, A Ekbom, et al.
Gut|March 1, 1997
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern NorwayB Moum, A Ekbom, M H Vatn, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of GastroenterologistsB Moum, M H Vatn, A Ekbom, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93B Moum, A Ekbom, M H Vatn, et al.
The American Journal of Gastroenterology|February 19, 1998
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistanceF Lerang, B Moum, E Ragnhildstveit, et al.
Scandinavian Journal of Gastroenterology|May 6, 2004
Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosisT Bernklev, J Jahnsen, E Aadland, et al.
The American Journal of Gastroenterology|January 5, 2002
Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first resultsI van der Eijk, H Sixma, T Smeets, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2001
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 monthsN J Talley, K Lauritsen, H Tunturi-Hihnala, et al.
Pageof 6